Augmentation of apoptosis and Interferon-γ production at sites of active mycobacterium tuberculosis infection in human tuberculosis

被引:86
作者
Hirsch, CS
Toossi, Z
Johnson, JL
Luzze, H
Ntambi, L
Peters, P
McHugh, M
Okwera, A
Joloba, M
Mugyenyi, P
Mugerwa, RD
Terebuh, P
Ellner, JJ
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[2] Vet Adm Med Ctr, Cleveland, OH 44106 USA
[3] Univ Med & Dent New Jersey, Newark, NJ 07103 USA
[4] Ugandan Minist Hlth, Natl TB & Leprosy Programme, Kampala, Uganda
[5] Makerere Univ, Kampala, Uganda
[6] Joint Clin Res Ctr, Kampala, Uganda
关键词
D O I
10.1086/318817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pleural tuberculosis (TB) was employed as a model to study T cell apoptosis at sites of active Mycobacterium tuberculosis (MTB) infection in human immunodeficiency virus (HIV)-coinfected (HIV/TB) patients and patients infected with TB alone. Apoptosis in blood and in pleural fluid mononuclear cells and cytokine immunoreactivities in plasma and in pleural fluid were evaluated. T cells were expanded at the site of MTB infection, irrespective of HIV status. Apoptosis of CD4 and non-CD4 T cells in the pleural space occurred in both HIV/TB and TB. Interferon (IFN)-gamma levels were increased in pleural fluid, compared with plasma. Spontaneous apoptosis correlated with specific loss of MTB-reactive, IFN-gamma -producing pleural T cells. Immunoreactivities of molecules potentially involved in apoptosis, such as tumor necrosis factor-alpha, Fas-ligand, and Fas, were increased in pleural fluid, compared with plasma. These data suggest that continued exposure of immunoreactive cells to MTB at sites of infection may initiate a vicious cycle in which immune activation and loss of antigen-responsive T cells occur concomitantly, thus favoring persistence of MTB infection.
引用
收藏
页码:779 / 788
页数:10
相关论文
共 42 条
[1]  
[Anonymous], DIAGNOSTIC STANDARDS
[2]   CYTOKINE PRODUCTION AT THE SITE OF DISEASE IN HUMAN TUBERCULOSIS [J].
BARNES, PF ;
LU, SZ ;
ABRAMS, JS ;
WANG, E ;
YAMAMURA, M ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3482-3489
[3]  
Baumler CB, 1996, BLOOD, V88, P1741
[4]   Hierarchical control of lymphocyte survival [J].
Boise, LH ;
Thompson, CB .
SCIENCE, 1996, 274 (5284) :67-68
[5]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[6]   Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays [J].
Der, SD ;
Zhou, AM ;
Williams, BRG ;
Silverman, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15623-15628
[7]   Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection [J].
Dorman, SE ;
Holland, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2364-2369
[8]   Fas-mediated apoptosis of CD4(+) and CD8(+) T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists [J].
Estaquier, J ;
Tanaka, M ;
Suda, T ;
Nagata, S ;
Golstein, P ;
Ameisen, JC .
BLOOD, 1996, 87 (12) :4959-4966
[9]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[10]   A license to kill [J].
Fraser, A ;
Evan, G .
CELL, 1996, 85 (06) :781-784